Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörn Sträter

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Vitamins and Hormones|April 28, 2004
TRAIL and viral infectionJörn Sträter, Peter Möller
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 30, 2005
Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFkappaB and IAPsCornelia Hasel, Umesh K Bhanot, René Heydrich, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Parenchymal regression in chronic pancreatitis spares islets reprogrammed for expression of NFkappaB and IAPs]Cornelia Hasel, Umesh K Bhanot, René Maier, et al.
International Journal of Cancer|December 17, 2009
Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosisJörn Sträter, Ines Herter, Gaby Merkel, et al.
Cancers|April 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EFGR Mutation, KRAS Mutation, or No MutationMartin Faehling, Sabine Fallscheer, Birgit Schwenk, et al.
Journal of Cancer Research and Clinical Oncology|August 1, 2018
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practiceMartin Faehling, Birgit Schwenk, Sebastian Kramberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2021
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative optionMartin Faehling, Sabine Fallscheer, Sebastian Kramberg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2025
Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutationMartin Faehling, Sabine Fallscheer, Julia Schmiederer, et al.
Oncotarget|November 5, 2017
Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practiceMartin Faehling, Birgit Schwenk, Sebastian Kramberg, et al.
Deutsche Medizinische Wochenschrift (1946)|November 27, 2009
[Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009]Karsten Müssig, Klaus Mörike, Reinhild Klein, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Vitamins and Hormones|April 28, 2004
TRAIL and viral infectionJörn Sträter, Peter Möller
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 30, 2005
Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFkappaB and IAPsCornelia Hasel, Umesh K Bhanot, René Heydrich, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Parenchymal regression in chronic pancreatitis spares islets reprogrammed for expression of NFkappaB and IAPs]Cornelia Hasel, Umesh K Bhanot, René Maier, et al.
International Journal of Cancer|December 17, 2009
Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosisJörn Sträter, Ines Herter, Gaby Merkel, et al.
Cancers|April 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EFGR Mutation, KRAS Mutation, or No MutationMartin Faehling, Sabine Fallscheer, Birgit Schwenk, et al.
Journal of Cancer Research and Clinical Oncology|August 1, 2018
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practiceMartin Faehling, Birgit Schwenk, Sebastian Kramberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2021
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative optionMartin Faehling, Sabine Fallscheer, Sebastian Kramberg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2025
Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutationMartin Faehling, Sabine Fallscheer, Julia Schmiederer, et al.
Oncotarget|November 5, 2017
Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practiceMartin Faehling, Birgit Schwenk, Sebastian Kramberg, et al.
Deutsche Medizinische Wochenschrift (1946)|November 27, 2009
[Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009]Karsten Müssig, Klaus Mörike, Reinhild Klein, et al.
Pageof 3